Claudin-7 down-regulation is an important feature in oral squamous cell carcinoma

Lourenço S V, Coutinho‐Camillo C M, Buim M E C, de Carvalho A C, Lessa R C, Pereira C M, Vettore A L, Carvalho A L, Fregnani J H, Kowalski L P & Soares F A 
(2010) Histopathology57, 689–698 
Claudin‐7 down‐regulation is an important feature in oral squamous cell carcinoma Aims:  Claudins, a larg...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Histopathology 2010-11, Vol.57 (5), p.689-698
Hauptverfasser: Lourenço, Silvia Vanessa, Coutinho-Camillo, Cláudia Malheiros, Buim, Marcilei Elisa Cavicchioli, De Carvalho, Ana Carolina, Lessa, Roberta Cardim, Pereira, Cláudia Maria, Vettore, André Luiz, Carvalho, André Lopes, Fregnani, José Humberto, Kowalski, Luiz Paulo, Soares, Fernando Augusto
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Lourenço S V, Coutinho‐Camillo C M, Buim M E C, de Carvalho A C, Lessa R C, Pereira C M, Vettore A L, Carvalho A L, Fregnani J H, Kowalski L P & Soares F A 
(2010) Histopathology57, 689–698 
Claudin‐7 down‐regulation is an important feature in oral squamous cell carcinoma Aims:  Claudins, a large family of essential tight junction (TJ) proteins, are abnormally regulated in human carcinomas, especially claudin‐7. The aim of this study was to investigate claudin‐7 expression and alterations in oral squamous cell carcinoma (OSCC). Methods and results:  Expression of claudin‐7 was analysed in 132 cases of OSCC organized in a tissue microarray. Claudin‐7 mRNA transcript was evaluated using real‐time polymerase chain reaction and the methylation status of the promoter was also assessed. Claudin‐7 was negative in 58.3% of the cases. Loss of claudin‐7 protein expression was associated with recurrence (P = 0.019), tumour size (P = 0.014), clinical stage of OSCC (P = 0.055) and disease‐free survival (P = 0.015). Down‐regulation of the claudin‐7 mRNA transcripts was observed in 78% of the cases, in accordance with immunoexpression. Analysis of the methylation status of the promoter region of claudin‐7 revealed that treatment of O28 cells (that did not express claudin‐7 mRNA transcripts) with 5‐Aza‐2′‐Deoxycytidine (5‐Aza‐dC) led to the re‐expression of claudin‐7 mRNA transcript. Conclusion:  Loss of claudin‐7 expression is associated with important subcellular processes in OSCC with impact on clinical parameters.
ISSN:0309-0167
1365-2559
DOI:10.1111/j.1365-2559.2010.03685.x